Urtoxazumab is a humanized monoclonal antibody against diarrhoea caused by Escherichia coli, serotype O121.

The drug is designed to bind to a toxin of this bacterium, so that it can be more easily broken down and eliminated from the body.

[1][2] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.